Table 3. Non-specific issues that could not be explained medically, complained by reviewed patients.
| Russell’s viper (n1 = 93) (n2 = 67) |
Merrem’s Hump-nosed viper (n1 = 49) (n2 = 49) |
Indian krait (n1 = 12) (n2 = 5) |
Common cobra (n1 = 0) (n2 = 2) |
Identified non/mildly venomous snakes (n1 = 15) (n2 = 19) |
Snake unidentified (n1 = 30) (n2 = 26) |
All (n1 = 199) (n2 = 168) |
||
|---|---|---|---|---|---|---|---|---|
| Non-specific | ||||||||
| Fatigue: n, (%) | Group I | 37 (40%) | 13 (27%) | 2 (17%) | 0 | 1 (7%) | 2 (7%) | 55 (27%) |
| Group II | 12 (18%) | 2 (4%) | 2 (40%) | 0 | 0 | 1 (4%) | 17 (10%) | |
| Body aches and pains: n, (%) | Group I | 17 (18%) | 13 (27%) | 2 (17%) | 0 | 1 (7%) | 2 (7%) | 35 (18%) |
| Group II | 3 (4%) | 0 | 0 | 0 | 0 | 0 | 3 (2%) | |
| Loss of appetite: n, (%) | Group I | 7 (8%) | 4 (8%) | 1 (8%) | 0 | 1 (7%) | 0 | 13 (7%) |
| Group II | 1 (1%) | 0 | 0 | 0 | 0 | 0 | 1 (1%) | |
| ‘Aura-like experience’: n, (%) | Group I | 7 (8%) | 2 (4%) | 0 | 0 | 0 | 0 | 9 (5%) |
| Group II | 2 (3%) | 0 | 0 | 0 | 0 | 0 | 2 (1%) | |
| Gray hair: n, (%) | Group I | 2 (3%) | 1 (2%) | 0 | 0 | 0 | 0 | 3 (2%) |
| Group II | 3 (4%) | 0 | 0 | 0 | 0 | 1(4%) | 4 (2%) | |
| Scalp hair loss: n, (%) | Group I | 1 (1%) | 0 | 0 | 0 | 1 (7%) | 0 | 2 (1%) |
| Group II | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
n1, number of patients in group I; n2, number of patients in group II